These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21208220)

  • 1. The CKLF1-C19 peptide attenuates allergic lung inflammation by inhibiting CCR3- and CCR4-mediated chemotaxis in a mouse model of asthma.
    Tian L; Li W; Wang J; Zhang Y; Zheng Y; Qi H; Guo X; Zhang Y; Ma D; Shen H; Wang Y
    Allergy; 2011 Feb; 66(2):287-97. PubMed ID: 21208220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two C-terminal peptides of human CKLF1 interact with the chemokine receptor CCR4.
    Wang Y; Zhang Y; Han W; Li D; Tian L; Yin C; Ma D
    Int J Biochem Cell Biol; 2008; 40(5):909-19. PubMed ID: 18069042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alleviation of murine allergic rhinitis by C19, a C-terminal peptide of chemokine-like factor 1 (CKLF1).
    Zheng Y; Guo C; Zhang Y; Qi H; Sun Q; Xu E; Zhang Y; Ma D; Wang Y
    Int Immunopharmacol; 2011 Dec; 11(12):2188-93. PubMed ID: 22001899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-terminal peptides of chemokine-like factor 1 signal through chemokine receptor CCR4 to cross-desensitize the CXCR4.
    Zhang Y; Tian L; Zheng Y; Qi H; Guo C; Sun Q; Xu E; Zhang Y; Ma D; Wang Y
    Biochem Biophys Res Commun; 2011 Jun; 409(2):356-61. PubMed ID: 21605546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C19, a C-terminal peptide of CKLF1, decreases inflammation and proliferation of dermal capillaries in psoriasis.
    Zheng Y; Wang Y; Zhang X; Tan Y; Peng S; Chen L; He Y
    Sci Rep; 2017 Oct; 7(1):13890. PubMed ID: 29066845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new antagonist for CCR4 attenuates allergic lung inflammation in a mouse model of asthma.
    Zhang Y; Wu Y; Qi H; Xiao J; Gong H; Zhang Y; Xu E; Li S; Ma D; Wang Y; Li W; Shen H
    Sci Rep; 2017 Nov; 7(1):15038. PubMed ID: 29118379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine-like factor 1-derived C-terminal peptides induce the proliferation of dermal microvascular endothelial cells in psoriasis.
    Tan Y; Wang Y; Li L; Xia J; Peng S; He Y
    PLoS One; 2015; 10(4):e0125073. PubMed ID: 25915746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine-like factor 1 is a functional ligand for CC chemokine receptor 4 (CCR4).
    Wang Y; Zhang Y; Yang X; Han W; Liu Y; Xu Q; Zhao R; Di C; Song Q; Ma D
    Life Sci; 2006 Jan; 78(6):614-21. PubMed ID: 16137713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted reduction of CCR4⁺ cells is sufficient to suppress allergic airway inflammation.
    Honjo A; Ogawa H; Azuma M; Tezuka T; Sone S; Biragyn A; Nishioka Y
    Respir Investig; 2013 Dec; 51(4):241-9. PubMed ID: 24238232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in pharmacological research of chemokine like factor 1 (CKLF1).
    Liu DD; Song XY; Yang PF; Ai QD; Wang YY; Feng XY; He X; Chen NH
    Cytokine; 2018 Feb; 102():41-50. PubMed ID: 29275012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and optimization of novel 3-piperazinylcoumarin antagonist of chemokine-like factor 1 with oral antiasthma activity in mice.
    Li G; Wang D; Sun M; Li G; Hu J; Zhang Y; Yuan Y; Ji H; Chen N; Liu G
    J Med Chem; 2010 Feb; 53(4):1741-54. PubMed ID: 20099827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemokine-like factor 1 induces asthmatic pathological change by activating nuclear factor-κB signaling pathway.
    Li G; Li GY; Wang ZZ; Ji HJ; Wang DM; Hu JF; Yuan YH; Liu G; Chen NH
    Int Immunopharmacol; 2014 May; 20(1):81-8. PubMed ID: 24583145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation.
    Perros F; Hoogsteden HC; Coyle AJ; Lambrecht BN; Hammad H
    Allergy; 2009 Jul; 64(7):995-1002. PubMed ID: 19630858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A CCL chemokine-derived peptide (CDIP-2) exerts anti-inflammatory activity via CCR1, CCR2 and CCR3 chemokine receptors: Implications as a potential therapeutic treatment of asthma.
    Méndez-Enríquez E; Medina-Tamayo J; Soldevila G; Fortoul TI; Anton B; Flores-Romo L; García-Zepeda EA
    Int Immunopharmacol; 2014 May; 20(1):1-11. PubMed ID: 24560857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. n-Nonanoyl-CC chemokine ligand 14, a potent CC chemokine ligand 14 analogue that prevents the recruitment of eosinophils in allergic airway inflammation.
    Forssmann U; Hartung I; Bälder R; Fuchs B; Escher SE; Spodsberg N; Dulkys Y; Walden M; Heitland A; Braun A; Forssmann WG; Elsner J
    J Immunol; 2004 Sep; 173(5):3456-66. PubMed ID: 15322211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of the new orally active CCR4 antagonist K327 on CCR4+CD4+ T cell migration into the lung of mice with ovalbumin-induced lung allergic inflammation.
    Sato T; Komai M; Iwase M; Kobayashi K; Tahara H; Ohshima E; Arai H; Miki I
    Pharmacology; 2009; 84(3):171-82. PubMed ID: 19713720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL26/eotaxin-3 is more effective to induce the migration of eosinophils of asthmatics than CCL11/eotaxin-1 and CCL24/eotaxin-2.
    Provost V; Larose MC; Langlois A; Rola-Pleszczynski M; Flamand N; Laviolette M
    J Leukoc Biol; 2013 Aug; 94(2):213-22. PubMed ID: 23532518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets Independently Recruit into Asthmatic Lungs and Models of Allergic Inflammation via CCR3.
    Shah SA; Kanabar V; Riffo-Vasquez Y; Mohamed Z; Cleary SJ; Corrigan C; James AL; Elliot JG; Shute JK; Page CP; Pitchford SC
    Am J Respir Cell Mol Biol; 2021 May; 64(5):557-568. PubMed ID: 33556295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel CC-chemokine receptor 3 antagonist, Ki19003, inhibits airway eosinophilia and subepithelial/peribronchial fibrosis induced by repeated antigen challenge in mice.
    Komai M; Tanaka H; Nagao K; Ishizaki M; Kajiwara D; Miura T; Ohashi H; Haba T; Kawakami K; Sawa E; Yoshie O; Inagaki N; Nagai H
    J Pharmacol Sci; 2010; 112(2):203-13. PubMed ID: 20134116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine receptor 4 plays a key role in T cell recruitment into the airways of asthmatic patients.
    Vijayanand P; Durkin K; Hartmann G; Morjaria J; Seumois G; Staples KJ; Hall D; Bessant C; Bartholomew M; Howarth PH; Friedmann PS; Djukanovic R
    J Immunol; 2010 Apr; 184(8):4568-74. PubMed ID: 20237293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.